FDA inspection
QuVa Pharma, Inc.: FDA inspection ending Aug 18, 2022
FDA inspection 1177937 · Voluntary Action Indicated (VAI) · Sugar Land, TX
Key facts
| Inspection ID | 1177937 |
|---|---|
| Firm | QuVa Pharma, Inc. |
| FEI number | 3012053582 |
| Address | 1075 W Park One Dr Ste 100 |
| City | Sugar Land |
| State | TX |
| ZIP | 77478 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Aug 18, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data